Form 4: Health Catalyst CFO Sells Shares for Tax Obligations

Health Catalyst's Chief Financial Officer, Jason Alger, sold 2,613 shares of common stock to cover tax withholding obligations related to Restricted Stock Unit vesting.

Summary

• Jason Alger, Chief Financial Officer of Health Catalyst, Inc. (HCAT), disposed of 2,613 shares of common stock.
• The transaction occurred on September 2, 2025, at a price of $3.3627 per share.
• This sale was a non-discretionary 'sell to cover' transaction, mandated by the Issuer's equity incentive plans to satisfy tax withholding obligations upon the vesting of Restricted Stock Units.
• Following this transaction, Mr. Alger directly beneficially owns 267,033 shares of Health Catalyst common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While shares were sold, it was a non-discretionary 'sell to cover' for tax purposes following RSU vesting, which is a positive compensation event for the executive. It does not indicate a lack of confidence in the company.

Positives

• The underlying event for the share disposition was the vesting of Restricted Stock Units, which represents a positive compensation event for the Chief Financial Officer.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Management Comments

• The sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction and does not provide information relevant to broader industry trends or competitive analysis.

Related Party Transactions

• The transaction involves the Chief Financial Officer of Health Catalyst, Inc. disposing of shares of the company's common stock, which is inherently a related party transaction as it involves an insider.

Stakeholder Impact

• Shareholders: The sale of a relatively small number of shares for tax purposes by a key executive is a routine event and is unlikely to have a significant impact on shareholder sentiment or the company's stock price.
• Employees: The vesting of Restricted Stock Units and subsequent 'sell to cover' is a common practice in equity compensation plans, which can be a positive for employee retention and motivation.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary 'sell to cover' transaction by a key executive to satisfy tax obligations upon RSU vesting. It does not reflect a discretionary sale or a change in the executive's confidence in the company, nor does it provide new information about the company's operational or financial performance. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Health Catalyst, HCAT, Jason Alger, CFO, SEC Form 4, Insider Transaction, Restricted Stock Units, Sell to Cover, Equity Compensation